Article info
PDFReview
Can I treat this pregnant patient with botulinum toxin?
- Correspondence to Catharine Sarah Pearce, 9 Baring Crescent, Exeter, Devon EX1 1TL, UK; pearcecs{at}cardiff.ac.uk
Citation
Can I treat this pregnant patient with botulinum toxin?
Publication history
- First published January 3, 2014.
Online issue publication
January 22, 2014
Article Versions
- Previous version (3 January 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia
- Botulinum toxin for writer’s cramp: a randomised, placebo-controlled trial and 1-year follow-up
- A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia
- Botulinum toxin in clinical practice
- British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin
- Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy
- Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis
- Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia
- Pattern of premature degenerative changes of the cervical spine in patients with spasmodic torticollis and the impact on the outcome of selective peripheral denervation
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®